UnitedHealth Group is currently undervalued due to an overblown market reaction to profitability challenges. Click here to ...

UnitedHealth Group (UNH), once considered a reliable pillar in the managed care space, has suffered a stock decline of more ...

UnitedHealth Group (NYSE:UNH) has tumbled roughly 42% year?to?date, driven by rising Medicare Advantage costs, a surprise CEO ...

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second quarter 2025 investor ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

UnitedHealth Group (UNH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports ...

The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...

UnitedHealth Group Inc. (NYSE: UNH) is one of the most oversold S&P 500 stocks so far in 2025. While the stock was down only marginally in 2024, it has declined substantially in 2025, placing it among ...

Medicare Advantage (MA) markets are highly concentrated across the country, according to a new study from KFF. | Medicare ...